• 1
    Cooper, M. D. and Alder, M. N., The evolution of adaptive immune systems. Cell 2006. 124: 815822.
  • 2
    Stavnezer, J., Guikema, J. E. and Schrader, C. E., Mechanism and regulation of class switch recombination. Ann. Rev. Immunol. 2008. 26: 261292.
  • 3
    Xu, Z., Zan, H., Pone, E. J., Mai, T. and Casali, P., Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat. Rev. Immunol. 2012. 12: 517–531.
  • 4
    Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. and Honjo, T., Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000. 102: 553563.
  • 5
    Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schäffer, A. A., Casali, P. and Cerutti, A., DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 2002. 3: 822829.
  • 6
    Schneider, P., The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 2005. 17: 282289.
  • 7
    Castigli, E., Wilson, S. A., Elkhal, A., Ozcan, E., Garibyan, L. and Geha, R. S., Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation. J. Allergy Clin. Immunol. 2007. 120: 885891.
  • 8
    Ozcan, E., Rauter, I., Garibyan, L., Dillon, S. R. and Geha, R. S., Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation. J. Allergy Clin. Immunol. 2011. 128: 601609; e601–e604.
  • 9
    Fagarasan, S. and Honjo, T., T-Independent immune response: new aspects of B-cell biology. Science 2000. 290: 8992.
  • 10
    He, B., Xu, W., Santini, P. A., Polydorides, A. D., Chiu, A., Estrella, J., Shan, M. et al., Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007. 26: 812826.
  • 11
    Katsenelson, N., Kanswal, S., Puig, M., Mostowski, H., Verthelyi, D. and Akkoyunlu, M., Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion. Eur. J. Immunol. 2007. 37: 17851795.
  • 12
    He, B., Santamaria, R., Xu, W., Cols, M., Chen, K., Puga, I., Shan, M. et al., The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat. Immunol. 2010. 11: 836845.
  • 13
    Castigli, E., Wilson, S. A., Garibyan, L., Rachid, R., Bonilla, F., Schneider, L. and Geha, R. S., TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 2005. 37: 829834.
  • 14
    Salzer, U., Chapel, H. M., Webster, A. D., Pan-Hammarstrom, Q., Schmitt-Graeff, A., Schlesier, M., Peter, H. H. et al., Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 2005. 37: 820828.
  • 15
    Cunningham-Rundles, C. and Bodian, C., Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 1999. 92: 3448.
  • 16
    Wehr, C., Peter, H. H. and Warnatz, K., Response: improving classification in CVID. Blood 2008. 112: 446447.
  • 17
    Almejun, M. B., Sajaroff, E., Galicchio, M., Oleastro, M., Bernasconi, A., Zelazko, M. and Danielian, S., Immunological characteristics and two novel mutations in TACI in a cohort of 28 pediatric patients with common variable immunodeficiency. J. Clin. Immunol. 2012. 32: 8997.
  • 18
    Pan, Q., Petit-Frére, C., Lähdesmäki, A., Gregorek, H., Chrzanowska, K. H. and Hammarström, L., Alternative end joining during switch recombination in patients with Ataxia-Telangiectasia. Eur. J. Immunol. 2002. 32: 13001308.
  • 19
    Bossen, C. and Schneider, P., BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 2006. 18: 263275.
  • 20
    Cunningham-Rundles, C., Radigan, L., Knight, A. K., Zhang, L., Bauer, L. and Nakazawa, A., TLR9 activation is defective in common variable immune deficiency. J. Immunol. 2006. 176: 19781987.
  • 21
    Yu, J. E., Knight, A. K., Radigan, L., Marron, T. U., Zhang, L., Sanchez-Ramon, S. and Cunningham-Rundles, C., Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J. Allergy Clin. Immunol. 2009. 124: 349356, 356; e341–e343.
  • 22
    Lee, J. J.-Y., Rauter, I., Garibyan, L., Ozcan, E., Sannikova, T., Dillon, S. R., Cruz, A. C. et al., The murine equivalent of the A181E TACI mutation associated with CVID severely impairs B-cell function. Blood 2009. 114: 22542262.
  • 23
    Siebenlist, U., Brown, K. and Claudio, E., Control of lymphocyte development by nuclear factor-kappaB. Nat. Rev. Immunol. 2005. 5: 435445.
  • 24
    Dedeoglu, F., Horwitz, B., Chaudhuri, J., Alt, F. W. and Geha, R. S., Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB. Int. Immunol. 2004. 16: 395404.
  • 25
    Fried, A. J., Rauter, I., Dillon, S. R., Jabara, H. and Geha, R. S., Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency. J. Allergy Clin. Immunol. 2011. 128: 226228.
  • 26
    Ku, C. L., von Bernuth, H., Picard, C., Zhang, S. Y., Chang, H. H., Yang, K., Chrabieh, M. et al., Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 2007. 204: 24072422.
  • 27
    Vinuesa, C., Linterman, M. A., Goodnow, C. C. and Randall, K. L., T cells and follicular dendritic cells in germinal center B-cell formation and selection. Immunol. Rev. 2010. 237: 7289.
  • 28
    Bossen, C., Cachero, T. G., Tardivel, A., Ingold, K., Willen, L., Dobles, M., Scott, M. L. et al., TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 2008. 111: 10041012.
  • 29
    Xia, X. Z., Treanor, J., Senaldi, G., Khare, S. D., Boone, T., Kelley, M., Theill, L. E. et al., TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B-cell regulation. J. Exp. Med. 2000. 192: 137143.
  • 30
    Ye, H. and Wu, H., Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry. Proc. Natl. Acad. Sci. USA 2000. 97: 89618966.
  • 31
    Baud, V., Liu, Z. G., Bennett, B., Suzuki, N., Xia, Y. and Karin, M., Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes. Dev. 1999. 13: 12971308.
  • 32
    Salzer, U., Bacchelli, C., Buckridge, S., Pan-Hammarström, Q., Jennings, S., Lougaris, V., Bergbreiter, A. et al., Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009. 113: 19671976.
  • 33
    Magerus-Chatinet, A., Neven, B., Stolzenberg, M. C., Daussy, C., Arkwright, P., Lanzarotti, N., Schaffner, C. et al., Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J. Clin. Invest. 2011. 121: 106112.
  • 34
    Pan-Hammarström, Q., Dai, S., Zhao, Y., Dijk-Hard, v., Gatti, R. A., Borresen-Dale, A. L. and Hammarstrom, L., ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region. J. Immunol. 2003. 170: 37073716.
  • 35
    Xu, W., Santini, P. A., Matthews, A. J., Chiu, A., Plebani, A., He, B., Chen, K. et al., Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. J. Immunol. 2008. 181: 276287.
  • 36
    Mohammadi, J., Liu, C., Aghamohammadi, A., Bergbreiter, A., Du, L., Lu, J., Rezaei, N. et al., Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J. Clin. Immunol. 2009. 29: 777785.